These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 26814757)

  • 1. An Update on the Use of Animal Models in Diabetic Nephropathy Research.
    Betz B; Conway BR
    Curr Diab Rep; 2016 Feb; 16(2):18. PubMed ID: 26814757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent advances in animal models of diabetic nephropathy.
    Betz B; Conway BR
    Nephron Exp Nephrol; 2014; 126(4):191-5. PubMed ID: 25034792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term expression of glomerular genes in diabetic nephropathy.
    Chittka D; Banas B; Lennartz L; Putz FJ; Eidenschink K; Beck S; Stempfl T; Moehle C; Reichelt-Wurm S; Banas MC
    Nephrol Dial Transplant; 2018 Sep; 33(9):1533-1544. PubMed ID: 29340699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of endothelial nitric oxide synthase in diabetic nephropathy: lessons from diabetic eNOS knockout mice.
    Takahashi T; Harris RC
    J Diabetes Res; 2014; 2014():590541. PubMed ID: 25371905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperglycemia and renin-dependent hypertension synergize to model diabetic nephropathy.
    Conway BR; Rennie J; Bailey MA; Dunbar DR; Manning JR; Bellamy CO; Hughes J; Mullins JJ
    J Am Soc Nephrol; 2012 Mar; 23(3):405-11. PubMed ID: 22193383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of susceptibility of inbred mouse strains to diabetic nephropathy.
    Qi Z; Fujita H; Jin J; Davis LS; Wang Y; Fogo AB; Breyer MD
    Diabetes; 2005 Sep; 54(9):2628-37. PubMed ID: 16123351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endothelial nitric oxide synthase deficiency produces accelerated nephropathy in diabetic mice.
    Zhao HJ; Wang S; Cheng H; Zhang MZ; Takahashi T; Fogo AB; Breyer MD; Harris RC
    J Am Soc Nephrol; 2006 Oct; 17(10):2664-9. PubMed ID: 16971655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological PAR-1 inhibition reduces blood glucose levels but does not improve kidney function in experimental type 2 diabetic nephropathy.
    Waasdorp M; Florquin S; Duitman J; Spek CA
    FASEB J; 2019 Oct; 33(10):10966-10972. PubMed ID: 31287960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modeling Human Diabetic Kidney Disease by Combining Hyperglycemia and Hypertension in a Transgenic Rodent Model.
    Cairns C; Conway B
    Methods Mol Biol; 2020; 2067():41-52. PubMed ID: 31701444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mouse models of diabetic nephropathy.
    Alpers CE; Hudkins KL
    Curr Opin Nephrol Hypertens; 2011 May; 20(3):278-84. PubMed ID: 21422926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The SGLT2 inhibitor empagliflozin ameliorates early features of diabetic nephropathy in BTBR ob/ob type 2 diabetic mice with and without hypertension.
    Gembardt F; Bartaun C; Jarzebska N; Mayoux E; Todorov VT; Hohenstein B; Hugo C
    Am J Physiol Renal Physiol; 2014 Aug; 307(3):F317-25. PubMed ID: 24944269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BTBR Ob/Ob mutant mice model progressive diabetic nephropathy.
    Hudkins KL; Pichaiwong W; Wietecha T; Kowalewska J; Banas MC; Spencer MW; Mühlfeld A; Koelling M; Pippin JW; Shankland SJ; Askari B; Rabaglia ME; Keller MP; Attie AD; Alpers CE
    J Am Soc Nephrol; 2010 Sep; 21(9):1533-42. PubMed ID: 20634301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deficiency of endothelial nitric-oxide synthase confers susceptibility to diabetic nephropathy in nephropathy-resistant inbred mice.
    Kanetsuna Y; Takahashi K; Nagata M; Gannon MA; Breyer MD; Harris RC; Takahashi T
    Am J Pathol; 2007 May; 170(5):1473-84. PubMed ID: 17456755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endothelial nitric oxide synthase.
    Nakagawa T; Johnson RJ
    Contrib Nephrol; 2011; 170():93-101. PubMed ID: 21659762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diabetic endothelial nitric oxide synthase knockout mice develop advanced diabetic nephropathy.
    Nakagawa T; Sato W; Glushakova O; Heinig M; Clarke T; Campbell-Thompson M; Yuzawa Y; Atkinson MA; Johnson RJ; Croker B
    J Am Soc Nephrol; 2007 Feb; 18(2):539-50. PubMed ID: 17202420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advances in murine models of diabetic nephropathy.
    Kong LL; Wu H; Cui WP; Zhou WH; Luo P; Sun J; Yuan H; Miao LN
    J Diabetes Res; 2013; 2013():797548. PubMed ID: 23844375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A susceptibility gene for kidney disease in an obese mouse model of type II diabetes maps to chromosome 8.
    Chua S; Li Y; Liu SM; Liu R; Chan KT; Martino J; Zheng Z; Susztak K; D'Agati VD; Gharavi AG
    Kidney Int; 2010 Sep; 78(5):453-62. PubMed ID: 20520596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of cross-species shared transcriptional networks of diabetic nephropathy in human and mouse glomeruli.
    Hodgin JB; Nair V; Zhang H; Randolph A; Harris RC; Nelson RG; Weil EJ; Cavalcoli JD; Patel JM; Brosius FC; Kretzler M
    Diabetes; 2013 Jan; 62(1):299-308. PubMed ID: 23139354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of O-linked N-acetylglucosamine modification in diabetic nephropathy.
    Gellai R; Hodrea J; Lenart L; Hosszu A; Koszegi S; Balogh D; Ver A; Banki NF; Fulop N; Molnar A; Wagner L; Vannay A; Szabo AJ; Fekete A
    Am J Physiol Renal Physiol; 2016 Dec; 311(6):F1172-F1181. PubMed ID: 27029430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel mouse model of advanced diabetic kidney disease.
    Thibodeau JF; Holterman CE; Burger D; Read NC; Reudelhuber TL; Kennedy CR
    PLoS One; 2014; 9(12):e113459. PubMed ID: 25514595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.